Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MDLN – Medline Inc

MDLN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.41

Margin Of Safety %

3

Put/Call OI Ratio

0.79

EPS Next Q Diff

-0.08

EPS Last/This Y

0.94

EPS This/Next Y

-0.02

Price

39.44

Target Price

45.38

Analyst Recom

1.57

Performance Q

13.16

Upside

-77.9%

Beta

Ticker: MDLN




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15MDLN36.581.200.4525482
2026-10-16MDLN35.951.200.9825509
2026-10-19MDLN35.21.282.5621738
2026-10-20MDLN35.461.010.9924937
2026-10-21MDLN35.291.010.5525013
2026-10-22MDLN34.871.010.0625464
2026-10-23MDLN34.081.190.5123741
2026-10-26MDLN33.681.190.0423798
2026-10-27MDLN32.381.100.1924907
2026-10-28MDLN32.361.060.5725519
2026-10-29MDLN321.060.2225791
2026-10-30MDLN32.121.033.8026263
2026-11-02MDLN33.631.432.6428841
2026-11-03MDLN34.121.4251.4228988
2026-11-04MDLN40.381.780.0638016
2026-11-05MDLN39.760.600.1064217
2026-11-06MDLN39.690.601.4065134
2026-11-09MDLN40.720.660.4870476
2026-11-10MDLN40.580.665.1370760
2026-11-11MDLN42.160.745.8375788
2026-11-12MDLN39.980.7916.3178047
2026-11-13MDLN39.440.7944.0078125
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15MDLN36.59- 1210.21.55
2026-10-16MDLN35.96- 1131.11.54
2026-10-19MDLN35.20- 1123.11.54
2026-10-20MDLN35.20- 1123.11.54
2026-10-21MDLN35.46- 1136.51.54
2026-10-22MDLN34.88- 1141.01.54
2026-10-23MDLN34.08- 1119.71.54
2026-10-26MDLN33.68- 1141.11.54
2026-10-27MDLN32.38- 1091.71.54
2026-10-28MDLN32.39- 1091.41.54
2026-10-29MDLN31.99- 1140.41.54
2026-10-30MDLN32.10- 1169.21.54
2026-11-02MDLN33.64- 1249.81.54
2026-11-03MDLN34.11- 1275.91.54
2026-11-04MDLN40.38- 1507.11.54
2026-11-05MDLN39.76- 1237.61.54
2026-11-06MDLN39.6529.31263.41.54
2026-11-09MDLN40.7129.31205.81.54
2026-11-10MDLN40.9126.61163.71.57
2026-11-11MDLN42.1626.61213.21.57
2026-11-12MDLN39.9826.81052.71.57
2026-11-13MDLN39.4426.81128.21.57
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15MDLN-19.2810.8210.33
2026-10-16MDLN-19.2810.8210.33
2026-10-19MDLN-26.3610.8510.33
2026-10-20MDLN-26.3610.8510.33
2026-10-21MDLN-19.2810.8510.33
2026-10-22MDLN-19.2810.8510.33
2026-10-23MDLN-19.2810.8510.33
2026-10-26MDLN-26.3613.8510.33
2026-10-27MDLN-19.2813.858.01
2026-10-28MDLN-19.2813.858.01
2026-10-29MDLN-19.2813.858.01
2026-10-30MDLN-19.2813.858.01
2026-11-02MDLN-19.288.628.01
2026-11-03MDLN-19.288.628.01
2026-11-05MDLN-19.288.628.01
2026-11-06MDLN-19.288.628.01
2026-11-09MDLN-19.278.267.99
2026-11-10MDLN-19.278.267.99
2026-11-11MDLN-19.278.267.41
2026-11-12MDLN-19.278.267.41
2026-11-13MDLN-19.278.267.41
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

0.42

Avg. EPS Est. Current Quarter

0.39

Avg. EPS Est. Next Quarter

0.34

Insider Transactions

-19.27

Institutional Transactions

8.26

Beta

Average Sales Estimate Current Quarter

8502

Average Sales Estimate Next Quarter

7874

Fair Value

40.71

Quality Score

57

Growth Score

Sentiment Score

66

Actual DrawDown %

22.5

Max Drawdown 5-Year %

Target Price

45.38

P/E

59

Forward P/E

25.44

PEG

3.46

P/S

1.69

P/B

2.94

P/Free Cash Flow

27.62

EPS

0.67

Average EPS Est. Cur. Y​

1.57

EPS Next Y. (Est.)

1.55

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.85

Relative Volume

0.89

Return on Equity vs Sector %

-21.6

Return on Equity vs Industry %

-4.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

1128.2
◆ MDLN Healthcare
$39.47
📉
Swing / Pullback
Buy the dip on strong trends
33 /100
WEAK
Trend
2/20
Pullback
10/25
Volume
4/15
Valuation
12/20
TP/AR
1/10
Options
4/10
RSI
60.4
Range 1M
81.5%
Sup Dist
0.7%
🚀
Momentum Growth
Ride accelerating trends
32 /100
WEAK
Momentum
9/25
Growth
12/30
Estimates
1/20
Inst/Vol
7/15
Options
3/10
EPS Yr
7.8%
EPS NY
0.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -20.5% upside
Quality
3/30
Valuation
1/30
Growth
7/25
Stability
7/10
LT Trend
1/5
Upside
-20.5%
Quality
57
MoS
3%
MDLN — P/E HistoricalMedical Instruments & Supplies
Medline Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 45000
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.
MDLN

Latest News

—
Caricamento notizie per MDLN…
stock quote shares MDLN – Medline Inc Stock Price stock today
news today MDLN – Medline Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDLN – Medline Inc yahoo finance google finance
stock history MDLN – Medline Inc invest stock market
stock prices MDLN premarket after hours
ticker MDLN fair value insiders trading

SOLV – Solventum Corp

SOLV — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.51

Margin Of Safety %

Put/Call OI Ratio

0.5

EPS Next Q Diff

0.26

EPS Last/This Y

1.13

EPS This/Next Y

0.3

Price

89.07

Target Price

99.82

Analyst Recom

2.31

Performance Q

2.57

Upside

-87.0%

Beta

0.72

Ticker: SOLV




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15SOLV87.830.280.1517542
2026-10-16SOLV85.720.280.0517535
2026-10-19SOLV85.060.210.199036
2026-10-20SOLV86.390.210.119080
2026-10-21SOLV86.670.210.399157
2026-10-22SOLV87.480.210.009180
2026-10-23SOLV85.430.200.339449
2026-10-26SOLV85.780.200.449460
2026-10-27SOLV83.040.200.179472
2026-10-28SOLV81.860.200.419459
2026-10-29SOLV83.570.200.009463
2026-10-30SOLV81.320.200.549475
2026-11-02SOLV84.750.200.269485
2026-11-03SOLV84.740.210.109515
2026-11-04SOLV89.290.210.059538
2026-11-05SOLV87.170.211.629396
2026-11-06SOLV90.380.510.1111375
2026-11-09SOLV90.460.510.1311419
2026-11-10SOLV90.030.500.1411471
2026-11-11SOLV88.620.500.4011490
2026-11-12SOLV88.790.500.1211488
2026-11-13SOLV89.030.500.0011495
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15SOLV87.83-9.8-1195.07.14
2026-10-16SOLV85.77-9.8-1218.67.14
2026-10-19SOLV85.07-9.8-1209.97.14
2026-10-20SOLV85.07-9.8-1209.97.14
2026-10-21SOLV86.37-9.8-1201.37.14
2026-10-22SOLV87.49-9.8-1199.67.14
2026-10-23SOLV85.40-9.8-1218.67.14
2026-10-26SOLV85.81-10.4-1202.47.14
2026-10-27SOLV83.04-10.4-1223.37.14
2026-10-28SOLV81.81-10.4-1231.47.18
2026-10-29SOLV83.56-10.4-1193.47.18
2026-10-30SOLV80.92-10.4-1222.87.18
2026-11-02SOLV84.74-10.4-1181.67.18
2026-11-03SOLV84.75-10.4-1182.87.18
2026-11-04SOLV89.34-10.4-1174.57.18
2026-11-05SOLV87.11-10.4-1219.47.18
2026-11-06SOLV90.35-10.4360.77.18
2026-11-09SOLV90.4814.2340.67.18
2026-11-10SOLV90.0813.0337.87.22
2026-11-11SOLV88.6213.0330.77.22
2026-11-12SOLV88.8212.9341.37.23
2026-11-13SOLV89.0712.9341.67.24
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15SOLV0.00-1.523.39
2026-10-16SOLV0.00-1.523.40
2026-10-19SOLV0.00-1.513.40
2026-10-20SOLV0.00-1.513.40
2026-10-21SOLV0.00-1.513.40
2026-10-22SOLV0.00-1.513.40
2026-10-23SOLV0.00-1.513.40
2026-10-26SOLV0.00-1.153.40
2026-10-27SOLV0.00-1.153.44
2026-10-28SOLV0.00-1.153.44
2026-10-29SOLV0.00-1.153.44
2026-10-30SOLV0.00-1.153.44
2026-11-02SOLV0.00-1.323.44
2026-11-03SOLV0.00-1.323.44
2026-11-05SOLV0.00-1.323.44
2026-11-06SOLV0.00-1.323.44
2026-11-09SOLV0.00-1.353.45
2026-11-10SOLV0.00-1.353.45
2026-11-11SOLV0.00-1.353.51
2026-11-12SOLV0.00-1.353.51
2026-11-13SOLV0.00-1.353.51
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

1.45

Avg. EPS Est. Current Quarter

1.77

Avg. EPS Est. Next Quarter

1.71

Insider Transactions

Institutional Transactions

-1.35

Beta

0.72

Average Sales Estimate Current Quarter

2086

Average Sales Estimate Next Quarter

2081

Fair Value

Quality Score

61

Growth Score

44

Sentiment Score

87

Actual DrawDown %

7.3

Max Drawdown 5-Year %

Target Price

99.82

P/E

99.7

Forward P/E

11.71

PEG

1.06

P/S

1.85

P/B

3.15

P/Free Cash Flow

EPS

0.89

Average EPS Est. Cur. Y​

7.24

EPS Next Y. (Est.)

7.54

Target Price Estimates Raised

2

Target Price Estimates Lowered

Profit Margin

1.91

Relative Volume

0.86

Return on Equity vs Sector %

-23.2

Return on Equity vs Industry %

-6.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.13

EBIT Estimation

341.6
◆ SOLV Healthcare
$89.05
📉
Swing / Pullback
Buy the dip on strong trends
31 /100
WEAK
Trend
0/20
Pullback
10/25
Volume
4/15
Valuation
8/20
TP/AR
4/10
Options
5/10
RSI
55.3
Range 1M
62.5%
Sup Dist
1.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
28 /100
WEAK
Momentum
4/25
Growth
9/30
Estimates
7/20
Inst/Vol
2/15
Options
6/10
EPS Yr
18.6%
EPS NY
4.9%
52W%
82.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +10.7% upside
Quality
6/30
Valuation
5/30
Growth
9/25
Stability
2/10
LT Trend
1/5
Upside
+10.7%
Quality
61
SOLV — P/E HistoricalMedical Instruments & Supplies
Solventum Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 20584
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
SOLV

Latest News

—
Caricamento notizie per SOLV…
stock quote shares SOLV – Solventum Corp Stock Price stock today
news today SOLV – Solventum Corp stock forecast ,stock prediction 2023 2024 2025
marketwatch SOLV – Solventum Corp yahoo finance google finance
stock history SOLV – Solventum Corp invest stock market
stock prices SOLV premarket after hours
ticker SOLV fair value insiders trading

STXS – Stereotaxis Inc.

STXS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.22

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

EPS Last/This Y

0.03

EPS This/Next Y

0.05

Price

0.83

Target Price

2.67

Analyst Recom

1

Performance Q

-40.29

Upside

-1,112.0%

Beta

1.4

Ticker: STXS




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15STXS1.0550.080.005187
2026-10-16STXS1.010.080.005166
2026-10-19STXS1.020.080.005139
2026-10-20STXS0.99250.080.005121
2026-10-21STXS0.98040.080.005128
2026-10-22STXS0.99010.080.005131
2026-10-23STXS1.0150.08999.995132
2026-10-26STXS0.99030.080.005132
2026-10-27STXS1.0250.080.005132
2026-10-28STXS0.97720.080.005142
2026-10-29STXS0.91070.063.335083
2026-10-30STXS0.85950.063.335083
2026-11-02STXS0.88010.063.335083
2026-11-03STXS0.85120.063.335083
2026-11-04STXS0.9530.060.005086
2026-11-05STXS1.040.060.005142
2026-11-06STXS1.110.060.005154
2026-11-09STXS1.150.060.005165
2026-11-10STXS1.050.060.005214
2026-11-11STXS0.90.060.135212
2026-11-12STXS0.8480.07999.995660
2026-11-13STXS0.8390.07999.995660
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15STXS1.0521.4- -0.21
2026-10-16STXS1.0121.4- -0.21
2026-10-19STXS1.0221.4- -0.21
2026-10-20STXS1.0221.4- -0.21
2026-10-21STXS0.9921.4- -0.21
2026-10-22STXS0.9921.4- -0.21
2026-10-23STXS1.0121.4- -0.21
2026-10-26STXS1.0021.4- -0.21
2026-10-27STXS1.0221.4- -0.21
2026-10-28STXS0.9721.4- -0.21
2026-10-29STXS0.9121.4- -0.21
2026-10-30STXS0.8621.4- -0.21
2026-11-02STXS0.8821.4- -0.21
2026-11-03STXS0.8521.4- -0.21
2026-11-04STXS0.9521.4- -0.21
2026-11-05STXS1.0421.4- -0.21
2026-11-06STXS1.1121.4- -0.21
2026-11-09STXS1.1421.4- -0.21
2026-11-10STXS1.0321.4- -0.21
2026-11-11STXS0.9021.4- -0.21
2026-11-12STXS0.8521.4- -0.21
2026-11-13STXS0.8316.7- -0.22
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15STXS0.000.537.38
2026-10-16STXS0.000.537.38
2026-10-19STXS0.000.507.38
2026-10-20STXS0.000.507.38
2026-10-21STXS0.000.507.38
2026-10-22STXS0.000.507.38
2026-10-23STXS0.000.507.38
2026-10-26STXS0.00-1.927.38
2026-10-27STXS0.00-1.927.79
2026-10-28STXS0.00-1.927.79
2026-10-29STXS0.00-1.927.79
2026-10-30STXS0.00-1.927.79
2026-11-02STXS0.00-2.347.79
2026-11-03STXS0.00-2.347.79
2026-11-05STXS0.00-2.347.79
2026-11-06STXS0.00-2.347.79
2026-11-09STXS0.00-0.847.79
2026-11-10STXS0.00-0.847.79
2026-11-11STXS0.00-0.847.22
2026-11-12STXS0.00-0.847.22
2026-11-13STXS0.00-0.847.22
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

-0.02

Insider Transactions

Institutional Transactions

-0.84

Beta

1.4

Average Sales Estimate Current Quarter

9

Average Sales Estimate Next Quarter

9

Fair Value

Quality Score

32

Growth Score

37

Sentiment Score

16

Actual DrawDown %

88.5

Max Drawdown 5-Year %

-87.7

Target Price

2.67

P/E

Forward P/E

PEG

P/S

2.64

P/B

3.92

P/Free Cash Flow

EPS

-0.24

Average EPS Est. Cur. Y​

-0.22

EPS Next Y. (Est.)

-0.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-74.86

Relative Volume

2.44

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-98.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ STXS Healthcare
$0.83
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
23/25
Volume
3/15
Valuation
12/20
TP/AR
2/10
Options
7/10
RSI
35.6
Range 1M
7.8%
Sup Dist
0.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
39 /100
WEAK
Momentum
13/25
Growth
18/30
Estimates
0/20
Inst/Vol
3/15
Options
5/10
EPS Yr
9.3%
EPS NY
30.9%
52W%
1.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +221.7% upside
Quality
5/30
Valuation
16/30
Growth
11/25
Stability
3/10
LT Trend
4/5
Upside
+221.7%
Quality
32
STXS — P/E HistoricalMedical Instruments & Supplies
Stereotaxis, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 131
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
STXS

Latest News

—
Caricamento notizie per STXS…
stock quote shares STXS – Stereotaxis Inc. Stock Price stock today
news today STXS – Stereotaxis Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch STXS – Stereotaxis Inc. yahoo finance google finance
stock history STXS – Stereotaxis Inc. invest stock market
stock prices STXS premarket after hours
ticker STXS fair value insiders trading

OSUR – OraSure Technologies Inc.

OSUR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

4.05

Margin Of Safety %

Put/Call OI Ratio

0.04

EPS Next Q Diff

0.05

EPS Last/This Y

0.13

EPS This/Next Y

0.08

Price

3.61

Target Price

5.5

Analyst Recom

2

Performance Q

-4.99

Upside

-347.8%

Beta

1.06

Ticker: OSUR




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15OSUR3.820.07999.99874
2026-10-16OSUR3.620.070.08875
2026-10-19OSUR3.690.030.05520
2026-10-20OSUR3.740.00999.993041
2026-10-21OSUR3.860.01999.993043
2026-10-22OSUR3.810.01999.993043
2026-10-23OSUR4.120.010.003042
2026-10-26OSUR4.160.0115.463068
2026-10-27OSUR4.160.07999.993281
2026-10-28OSUR4.080.070.003283
2026-10-29OSUR4.090.070.003283
2026-10-30OSUR3.930.070.003283
2026-11-02OSUR3.450.050.004783
2026-11-03OSUR3.540.050.074876
2026-11-04OSUR3.710.050.074876
2026-11-05OSUR3.370.05999.994900
2026-11-06OSUR3.440.050.004899
2026-11-09OSUR3.490.050.004899
2026-11-10OSUR3.330.04999.995895
2026-11-11OSUR3.550.04999.995895
2026-11-12OSUR3.620.040.005895
2026-11-13OSUR3.620.040.005897
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-15OSUR3.82-38.5- -0.80
2026-10-16OSUR3.62-38.5- -0.80
2026-10-19OSUR3.70-38.5- -0.80
2026-10-20OSUR3.70-38.5- -0.80
2026-10-21OSUR3.74-38.5- -0.80
2026-10-22OSUR3.81-38.5- -0.80
2026-10-23OSUR4.13-38.5- -0.80
2026-10-26OSUR4.16-38.5- -0.80
2026-10-27OSUR4.17-38.5- -0.80
2026-10-28OSUR4.09-38.5- -0.80
2026-10-29OSUR4.09-38.5- -0.80
2026-10-30OSUR3.94-38.5- -0.80
2026-11-02OSUR3.46-38.5- -0.80
2026-11-03OSUR3.53-38.5- -0.80
2026-11-04OSUR3.72-38.5- -0.80
2026-11-05OSUR3.36-38.5- -0.80
2026-11-06OSUR3.45-38.5- -0.80
2026-11-09OSUR3.51-38.5- -0.80
2026-11-10OSUR3.32-38.5- -0.80
2026-11-11OSUR3.55-38.5- -0.80
2026-11-12OSUR3.62-38.5- -0.80
2026-11-13OSUR3.6155.5- -0.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-15OSUR1.67-1.574.55
2026-10-16OSUR1.67-1.574.55
2026-10-19OSUR1.67-2.014.55
2026-10-20OSUR1.67-2.014.55
2026-10-21OSUR1.67-2.014.55
2026-10-22OSUR1.67-2.014.55
2026-10-23OSUR1.67-2.014.55
2026-10-26OSUR1.67-1.994.55
2026-10-27OSUR1.67-1.994.24
2026-10-28OSUR1.67-1.994.24
2026-10-29OSUR1.67-1.994.24
2026-10-30OSUR1.67-1.994.24
2026-11-02OSUR1.67-1.504.24
2026-11-03OSUR1.67-1.504.24
2026-11-05OSUR1.67-1.504.24
2026-11-06OSUR1.67-1.504.24
2026-11-09OSUR1.67-2.234.24
2026-11-10OSUR1.67-2.234.24
2026-11-11OSUR1.67-2.234.06
2026-11-12OSUR1.67-2.234.05
2026-11-13OSUR1.67-2.234.05
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-0.18

Avg. EPS Est. Current Quarter

-0.08

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

1.67

Institutional Transactions

-2.23

Beta

1.06

Average Sales Estimate Current Quarter

30

Average Sales Estimate Next Quarter

29

Fair Value

Quality Score

37

Growth Score

30

Sentiment Score

77

Actual DrawDown %

64.8

Max Drawdown 5-Year %

-79.3

Target Price

5.5

P/E

Forward P/E

PEG

P/S

2.15

P/B

0.81

P/Free Cash Flow

EPS

-0.69

Average EPS Est. Cur. Y​

-0.56

EPS Next Y. (Est.)

-0.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-41.73

Relative Volume

0.71

Return on Equity vs Sector %

-42.2

Return on Equity vs Industry %

-25.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ OSUR Healthcare
$3.62
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
19/25
Volume
9/15
Valuation
10/20
TP/AR
1/10
Options
8/10
RSI
47.6
Range 1M
31.4%
Sup Dist
4.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
23 /100
WEAK
Momentum
2/25
Growth
14/30
Estimates
0/20
Inst/Vol
1/15
Options
6/10
EPS Yr
36.7%
EPS NY
-3.4%
52W%
61.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +51.9% upside
Quality
5/30
Valuation
12/30
Growth
11/25
Stability
8/10
LT Trend
2/5
Upside
+51.9%
Quality
37
OSUR — P/E HistoricalMedical Instruments & Supplies
OraSure Technologies, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 500
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania.
OSUR

Latest News

—
Caricamento notizie per OSUR…
stock quote shares OSUR – OraSure Technologies Inc. Stock Price stock today
news today OSUR – OraSure Technologies Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OSUR – OraSure Technologies Inc. yahoo finance google finance
stock history OSUR – OraSure Technologies Inc. invest stock market
stock prices OSUR premarket after hours
ticker OSUR fair value insiders trading

EKSO – Ekso Bionics Holdings Inc.

EKSO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.97

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

1.98

EPS Last/This Y

4.47

EPS This/Next Y

0.37

Price

11.65

Target Price

90

Analyst Recom

3

Performance Q

25.93

Upside

N/A

Beta

0.86

Ticker: EKSO




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-15EKSO11.8N/AN/A0
2026-10-16EKSO11.8N/AN/A0
2026-10-19EKSO11.8N/AN/A0
2026-10-20EKSO11.8N/AN/A0
2026-10-21EKSO11.8N/AN/A0
2026-10-22EKSO11.8N/AN/A0
2026-10-23EKSO11.8N/AN/A0
2026-10-26EKSO11.8N/AN/A0
2026-10-27EKSO11.8N/AN/A0
2026-10-28EKSO11.8N/AN/A0
2026-10-29EKSO11.8N/AN/A0
2026-10-30EKSO11.8N/AN/A0
2026-11-02EKSO11.8N/AN/A0
2026-11-03EKSO11.8N/AN/A0
2026-11-04EKSO11.8N/AN/A0
2026-11-05EKSO11.8N/AN/A0
2026-11-06EKSO11.8N/AN/A0
2026-11-09EKSO11.8N/AN/A0
2026-11-10EKSO11.8N/AN/A0
2026-11-11EKSO11.8N/AN/A0
2026-11-12EKSO11.8N/AN/A0
2026-11-13EKSO11.8N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




No data found




No data found

Last Quarter Act. EPS​

-2.04

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

9.4

Institutional Transactions

-0.34

Beta

0.86

Average Sales Estimate Current Quarter

4

Average Sales Estimate Next Quarter

6

Fair Value

Quality Score

30

Growth Score

30

Sentiment Score

84

Actual DrawDown %

87.3

Max Drawdown 5-Year %

-96.8

Target Price

90

P/E

Forward P/E

PEG

P/S

3.64

P/B

20.12

P/Free Cash Flow

EPS

-5.39

Average EPS Est. Cur. Y​

-0.43

EPS Next Y. (Est.)

-0.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-138.91

Relative Volume

1

Return on Equity vs Sector %

-303.4

Return on Equity vs Industry %

-285.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

EKSO — P/E HistoricalMedical Instruments & Supplies
Sector:
Industry:
Employees:
EKSO

Latest News

—
Caricamento notizie per EKSO…
stock quote shares EKSO – Ekso Bionics Holdings Inc. Stock Price stock today
news today EKSO – Ekso Bionics Holdings Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EKSO – Ekso Bionics Holdings Inc. yahoo finance google finance
stock history EKSO – Ekso Bionics Holdings Inc. invest stock market
stock prices EKSO premarket after hours
ticker EKSO fair value insiders trading